Aura Biosciences, Inc. AURA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$33.69M-22.6% | -$25.56M+1.1% | -$26.13M-24.2% | -$27.02M-32.9% | -$27.48M-39.5% | ||
| $274K-5.8% | $272K-6.5% | $300K0.0% | $300K0.0% | $291K-4.9% | ||
| $3.82M+8.8% | $3.28M+11.7% | $3.69M+34.1% | $3.83M+22.6% | $3.51M+20.8% | ||
| $1.02M+444% | -$430K-239% | —— | -$720K-33.3% | -$298K-1,396% | ||
| -$2.75M-10.9% | $0— | $3.35M+6.5% | $3.39M— | -$2.48M+14.5% | ||
| $46K+109% | —— | —— | —— | -$518K-825% | ||
| -$386K-18.8% | -$377K-19.7% | -$358K— | -$332K-16.1% | -$325K-37.1% | ||
| -$29.89M-28.0% | -$20.47M+14.5% | -$20.14M-31.9% | -$20.77M-28.8% | -$23.36M+4.5% | ||
| $102K-45.5% | $176K-41.1% | $45K-86.8% | $39K-92.6% | $187K+113% | ||
| $54.9M+84.1% | $29.82M+0.4% | —— | $19.98M+0.7% | $29.81M+217% | ||
| $56K— | —— | —— | $46.52M+29,541% | $0-100% | ||
| $300K+213% | $2.77M+410% | $4.36M+509% | $69.93M+84,152% | $96K-62.1% | ||
| -$27K-28.6% | -$160K— | -$14K— | $0— | -$21K— | ||
| $25.31M+286% | $12.12M— | —— | $69.13M— | $6.55M+144% | ||
| $274K-5.8% | $272K-6.5% | $300K0.0% | $300K0.0% | $291K-4.9% | ||
| —— | —— | —— | —— | —— | ||
| -$386K-18.8% | -$377K-19.7% | -$358K— | -$332K-16.1% | -$325K-37.1% | ||
| -$1.73M+42.5% | -$2.68M-731% | —— | —— | -$3M-180% | ||
| $412K+10.2% | $402K+10.1% | $392K-1.3% | $383K+6.4% | $374K+5.9% | ||
| $0-100% | —— | —— | —— | $27K+2,260% | ||
| —— | —— | —— | —— | —— | ||
| $121K+26.0% | —— | $68K-17.1% | —— | $96K+1.1% | ||
| $123K— | —— | —— | —— | $0— | ||
| $20K— | $91K— | $0— | $0-100% | $0-100% | ||
| -$27K-28.6% | -$160K— | -$14K— | $0— | -$21K— | ||
| -$386K-18.8% | -$377K-19.7% | -$358K— | -$332K-16.1% | -$325K-37.1% | ||
| —— | $3.54M— | $3.54M— | $3.54M— | $3.54M— | ||
| -$30M-27.4% | -$20.65M+14.9% | -$20.19M-29.3% | -$20.81M-25.0% | -$23.54M+4.1% | ||
| -$30M-27.4% | -$20.65M+14.9% | -$20.19M-29.3% | -$20.81M-25.0% | -$23.54M+4.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Aura Biosciences, Inc. generate?
- Aura Biosciences, Inc. (AURA) generated -$91.3M in operating cash flow over the trailing twelve months.
- What is Aura Biosciences, Inc.'s free cash flow?
- After $362.0K of capital expenditures, Aura Biosciences, Inc.'s free cash flow was -$91.6M over the trailing twelve months, down 14.5% year over year.
- Where does Aura Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.